Nuestro cerebro está formado por miles de millones de neuronas que están conectadas entre sí formando redes complejas. Estas neuronas se comunican mediante un proceso llamado transmisión sináptica, en el cual se envían señales eléctricas, poten …
Controlando la actividad neuronal con fotones como neurotransmisores Read More »
La alergia a los cacahuetes es una de las más comunes. Según algunas estimaciones, afecta a 1 de cada 50 niños, y los casos más graves conducen a una reacción inmunitaria potencialmente mortal llamada shock anafiláctico. Actualmente, solo existe un …
Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the launch of a Phase I clinical trial of STP122G based on the Group’s GalNAc Factor XI Program.
Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program Read More »
CANbridge Pharmaceuticals, Inc. announced that the American Society for Gene and Cell Therapy has accepted the following abstract for presentation at the ASCGT Annual Meeting, May 16-20, in Los Angeles, CA.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced the U.S. Food and Drug Administration has placed a partial clinical hold on the initiation of new patients on evobrutinib and patients with less than 70 days exposure to study medication in the U.S.
HUTCHMED Limited announces that new and updated clinical and non-clinical data related to five HUTCHMED investigational drug candidates will be presented during the American Association for Cancer Research Annual Meeting 2023, which will take place from April 14 to 19, 2023 in Orlando, Florida.
InflaRx N.V., a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced the pricing of its underwritten public offering of 9,411,765 ordinary shares at an offering price of $4.25 per ordinary share.
InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares Read More »
Las baterías eléctricas basadas en agua cuentan con la obvia ventaja de que es imposible que se incendien, debido a su alto contenido acuoso. Ahora, además, unos científicos han descubierto una vía hacia un aumento en su capacidad de almacenamiento energétic …
Salto espectacular de la capacidad de almacenamiento en las baterías de agua Read More »
Chitose Laboratory Corp. has won funding from a Japanese government-affiliated entity for a project on the self-proposed theme of “Building a global industry originating in Japan based on the direct use of CO2 through photosynthesis” for the “Green Innovation Fund Project : Promotion of Carbon Recycling Using CO2 from Biomanufacturing Technology as a Direct Raw
ImaginAb Inc. is pleased to announce the execution of a new non-exclusive License and Supply Agreement with Leucid Bio, a biotech company pursuing a differentiated approach to develop next generation Chimeric Antigen Receptor T-cell therapies using the Company’s proprietary Lateral CAR Platform.
